Immuneering (IMRX) Stock Price
Immuneering Price
Revenue at Immuneering has contracted by 87.6% per year over the past 4 years to 455.00 USD. Immuneering's net margin stands at -11,752,005.0%, down from -401.6% several years earlier. Analysts set a median price target of 14.00 USD, implying 262.7% above the current price. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus.
Immuneering stock price
Immuneering business model & stock analysis
Frequently asked questions about Immuneering
Analysts currently set an average price target of 14.33 USD for the Immuneering stock (median: 14.00 USD), implying +271.2 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Immuneering stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Immuneering to generate revenue of 21.27 M USD and earnings per share of -1.12 USD.
Converted at the current exchange rate, the Immuneering share trades at 3.44 EUR (3.86 USD).
The Immuneering share (IMRX) is listed on 1 stock exchanges, including: NASDAQ (IMRX).
The expected revenue of Immuneering is 21.27 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Immuneering is -72.23 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Immuneering is currently -3.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Immuneering stock.
The price-to-sales ratio (P/S) of Immuneering is currently 11.72. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Immuneering stock.
The Eulerpool Quality Score for Immuneering is 2/10.
The ISIN of Immuneering is US45254E1073. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Immuneering is IMRX. The ticker symbol is used to trade Immuneering shares on the stock exchange.
Immuneering stock
Immuneering Peer Group
Immuneering Ticker
Immuneering FIGI
All fundamentals and in-depth analysis of Immuneering
Our stock analysis for Immuneering stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Immuneering. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.